The MYH9 Cytoskeletal Protein Is a Novel Corepressor of Androgen Receptors
In the progression of castration-resistant prostate cancer (CRPC), the androgen receptor (AR) that serves as a transcription factor becomes the most remarkable molecule. The transcriptional activity of AR is regulated by various coregulators. As a result, altered expression levels, an aberrant locat...
Hlavní autoři: | , , , , , , |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
Frontiers Media S.A.
2021-04-01
|
Edice: | Frontiers in Oncology |
Témata: | |
On-line přístup: | https://www.frontiersin.org/articles/10.3389/fonc.2021.641496/full |